Showing posts with label top stock gainers. Show all posts
Showing posts with label top stock gainers. Show all posts

Friday, April 7, 2017

Akorn, Inc. (ARKX) Shares Up on Rumor It’s a Takeover Target; The Company Confirms

Akorn Pharmaceuticals (NASDAQ- AKRX)

Akorn, Inc. (NASDAQ:AKRX) investors are overwhelmingly excited today following an earlier report from Bloomberg, claiming that European health-care provider Kabi Fresenius is considering a bid for the drug maker. Akorn shares reacted to the news, jumping nearly 18% to $29.77.
Following the closing bell, Akorn confirmed that it’s currently in discussions with Fresenius concerning a potential acquisition of Akorn, triggering another rise in share prices.
On the ratings front, Akorn has been the subject of a number of recent research reports. In a report issued on April 4, Jefferies analyst David Steinberg reiterated a Buy rating on AKRX, with a price target of $24, which implies a downside of 19% from current levels. Separately, on March 6, Deutsche Bank’s Gregg Gilbert downgraded the stock to Hold and has a price target of $24.
According to TipRanks.com, which ranks over 7,500 financial analysts and bloggers to gauge the performance of their past recommendations, David Steinberg and Gregg Gilbert have a yearly average return of 0.4% and a loss of -2.3% respectively. Steinberg has a success rate of 45% and is ranked #2574 out of 4556 analysts, while Gilbert has a success rate of 46% and is ranked #3933.
Akorn, Inc. is a niche pharmaceutical company that develops, manufactures and markets generic and prescription pharmaceuticals, as well as, animal and consumer health products. It operates through the Prescription Pharmaceuticals and Consumer Health segments. The Prescription Pharmaceuticals segment engages in the sales of generic and branded prescription pharmaceuticals including ophthalmics, injectables, oral liquids, otics, topicals, inhalants, and nasal sprays. The Consumer Health segment engages in the sales of animal health and over-the-counter products, both branded and private label.

Friday, March 31, 2017

Week in Review: Stocks Shake Off Health Care Worries to Climb for Week, First Quarter

Wall Street ends the week, and first quarter, with gains as stocks shrug off worries over the Trump administration to continue their grind higher.


Wall Street ended the week, and first quarter, with gains as stocks shrugged off worries over the Trump administration to continue their grind higher.
Image result for businessman reading newspaperThe Dow Jones Industrial Average began the week with another day of losses, extending its streak to an eighth day and the worst since 2011. However, the Dow and other benchmark indexes turned around to post gains for the whole week.
The worry had been that Donald Trump and House Republicans' failure to push health care reform through to a vote signaled trouble for the likelihood of other campaign promises, including tax cuts and infrastructure spending. That concern was mostly placed on the backburner this week with investors preferring to give Trump the benefit of the doubt.
"You can rationalize the lack of a sell-off by arguing that the health care debacle has no impact on tax reform," Vincent Deluard, vice president of global macro research at the BD Division of INTL FCStone Financial, told TheStreet. "It is difficult to predict U.S. legislation in general, and almost impossible in the age of Trump. The only forecast I would make is that the stock market has priced in a big tax deal for both corporations and individuals, and that it will be disappointed if it does not get it."
The GOP's failure to repeal and replace Obamacare, a major campaign commitment, had previously been viewed as a litmus test for Trump's ability to achieve major change in Washington. Trump had promised major tax reform and regulatory rollbacks, both which look like tougher sells after the clumsy handling of health care reform -- the bill appeared to be rushed through and was pushed toward a vote even without a healthy margin of support in Congress. The bill was pulled late Friday afternoon after two days of voting delays. House Speaker Paul Ryan said Tuesday that he had not formulated a timeline for a fresh attempt at health care reform.
The Dow ended the week 0.32% higher, the S&P 500 climbed 0.80%, and the Nasdaq rose 1.4%. Benchmark indexes fared even better over the first quarter, benefiting from the height of the "Trump rally." The Nasdaq logged the best gains of the three major benchmark indexes with an increase of 10% over the first three months of the year. The S&P 500 closed up nearly 6% for the first quarter, while the Dow rose almost 5%. The Dow's gain is its sixth quarterly increase in a row, the longest stretch since the end of 2006.
The United Kingdom took the expected first step to formally remove itself from the European Union earlier this week, a relationship that has lasted more than four decades. U.K. Prime Minister Theresa May activated Article 50 of the Lisbon Treaty Wednesday morning by notifying European Council President Donald Tusk by way of letter. The notification kicks off two years of negotiating trade, immigration, and other economic deals between the U.K. and the EU.
The U.K. voted in favor of "Brexit" last summer in a shock win that rocked markets at the time. However, global markets mostly have readjusted to the new reality just as they did following Trump's surprise election win in November. Analysts note that the long lead time heading into Article 50 means that markets have mostly priced in the move by Wednesday.
The U.S. economy grew at a faster pace than anticipated in the fourth quarter, further proof that the president inherited a solid economic foundation from predecessor Barack Obama despite Trump's calls to the contrary. The economy grew at a pace of 2.1% from October to December, up from a previous estimate of 1.9%, according to the third and final estimate of fourth-quarter GDP. Analysts anticipated the measure to tick up to 2% growth over the period, the final full quarter under the Obama administration.
Consumer confidence surged in March, continuing upward trends seen in the past few months. Confidence rose to a reading of 125.6 in March, according to the Conference Board, the highest level since December 2000. The index sat at 116.1 in February. Analysts had anticipated a small dip in March after the index reached a post-recession high last month.
Crude oil closed with quarterly losses of 5.8%, even as the commodity settled Friday at its best level in more than three weeks. Oil had a positive week as a weekly reading on domestic inventories showed a smaller-than-expected rise and production disruptions in Libya increased hopes of a hit to global output.
It was a quiet week on the earnings calendar. BlackBerry (BBRY) narrowed its loss from a year earlier and posted above-consensus adjusted profit. The company anticipates adjusted earnings over fiscal 2018.
Lululemon Athletica (LULU) issued a weak outlook for the first quarter. The athletic apparel brand anticipates first-quarter revenue no higher than $515 million and earnings between 25 cents to 27 cents a share. Analysts anticipated earnings of 39 cents a share on sales of $552 million. Fourth-quarter earnings also missed estimates.

Wednesday, February 15, 2017

Today : NASDAQ Most Advanced Stocks ( Top Percentage Gainers )

Image result for nasdaq today

NASDAQ Most Advanced

SymbolCompanyLast Sale*Change Net / %Share Volume

IEPRR

Icahn Enterprises L.P.Icahn Enterprises L.P.$ 3.861.06 ▲ 37.86%105,738

NOVN

Novan, Inc.$ 6.441.65 ▲ 34.45%5,430,657

EDIT

Editas Medicine, Inc.$ 24.305.44 ▲ 28.84%5,592,240

MDCA

MDC Partners Inc.MDC Partners Inc.$ 8.651.90 ▲ 28.15%2,973,784

GRPN

Groupon, Inc.Groupon, Inc.$ 4.640.86 ▲ 22.75%77,361,898

WIX

Wix.com Ltd.Wix.com Ltd.$ 61.508.55 ▲ 16.15%2,353,963

DRNA

Dicerna Pharmaceuticals, Inc.Dicerna Pharmaceuticals, Inc.$ 3.220.40 ▲ 14.18%729,827

ARDX

Ardelyx, Inc.Ardelyx, Inc.$ 131.55 ▲ 13.54%797,428

BBOX

Black Box CorporationBlack Box Corporation$ 10.101.15 ▲ 12.85%310,113

INSY

Insys Therapeutics, Inc.Insys Therapeutics, Inc.$ 10.821.18 ▲ 12.24%3,235,533

IVTY

Invuity, Inc.$ 7.800.85 ▲ 12.23%288,594

FNBC

First NBC Bank Holding Company$ 5.050.55 ▲ 12.22%877,874

NVET

Nexvet Biopharma plc$ 3.420.37 ▲ 12.13%31,590

ZGNX

Zogenix, Inc.Zogenix, Inc.$ 10.801.15 ▲ 11.92%604,100

GHDX

Genomic Health, Inc.Genomic Health, Inc.$ 31.122.89 ▲ 10.24%412,216

YY

YY Inc.YY Inc.$ 48.214.24 ▲ 9.64%2,490,304

CORI

Corium International, Inc.Corium International, Inc.$ 3.190.27 ▲ 9.25%1,953,247

IMDZ

Immune Design Corp.$ 60.50 ▲ 9.09%80,659

SBBP

Strongbridge Biopharma plc$ 2.500.20 ▲ 8.70%106,708

GNCA

Genocea Biosciences, Inc.$ 4.930.38 ▲ 8.35%316,035
As of 2/15/2017 4:00:00 PM
Visit or Gloassary for a definition of Volume 
* All values included in the "Most Active Share Volume" are calculated using the NASDAQ Market Center trades only.

Source: http://www.nasdaq.com/markets/most-active.aspx#ixzz4YnINa6DY

Tuesday, January 24, 2017

Today : NASDAQ Most Advanced Stocks


Image result for nasdaq

NASDAQ Most Advanced

SymbolCompanyLast Sale*Change Net / %Share Volume

ASYS

Amtech Systems, Inc.Amtech Systems, Inc.$ 5.831.72 ▲ 41.85%2,952,542

AVNW

Aviat Networks, Inc.Aviat Networks, Inc.$ 12.341.99 ▲ 19.23%32,775

AUPH

Aurinia Pharmaceuticals Inc$ 3.130.50 ▲ 19.01%5,992,199

IVAC

Intevac, Inc.Intevac, Inc.$ 9.751.45 ▲ 17.47%1,444,392

IIVI

II-VI IncorporatedII-VI Incorporated$ 36.054.65 ▲ 14.81%2,326,681

NVIV

InVivo Therapeutics Holdings Corp.$ 4.750.55 ▲ 13.10%565,925

WLB

Westmoreland Coal Company$ 17.991.74 ▲ 10.71%326,674

HOVNP

Hovnanian Enterprises Inc$ 8.390.79 ▲ 10.39%15,897

PTI

Proteostasis Therapeutics, Inc.$ 11.861.09 ▲ 10.12%89,501

VNRCP

Vanguard Natural Resources LLCVanguard Natural Resources LLC$ 3.760.34 ▲ 9.94%45,789

CENX

Century Aluminum CompanyCentury Aluminum Company$ 15.721.415 ▲ 9.89%9,234,230

GLDD

Great Lakes Dredge & Dock CorporationGreat Lakes Dredge & Dock Corporation$ 50.45 ▲ 9.89%329,628

CATB

Catabasis Pharmaceuticals, Inc.$ 4.560.40 ▲ 9.62%211,459

LITE

Lumentum Holdings Inc.Lumentum Holdings Inc.$ 37.703.30 ▲ 9.59%1,548,419

PPBI

Pacific Premier Bancorp Inc$ 39.253.25 ▲ 9.03%758,401

FSTR

L.B. Foster Company$ 14.701.15 ▲ 8.49%69,864

MRCY

Mercury Systems IncMercury Systems Inc$ 34.072.63 ▲ 8.37%2,226,487

CALA

Calithera Biosciences, Inc.Calithera Biosciences, Inc.$ 4.750.35 ▲ 7.95%174,670

AMRB

American River BanksharesAmerican River Bankshares$ 14.881.09 ▲ 7.90%43,424

GNBC

Green Bancorp, Inc.Green Bancorp, Inc.$ 15.101.10 ▲ 7.86%175,661
As of 1/24/2017 4:00:00 PM
Visit or Glossary for a definition of Volume 

Source: http://www.nasdaq.com/markets/most-active.aspx#ixzz4WjWosDmK